Art

J-GLOBAL ID：202002274317372566   Reference number：20A0560451

水疱をどう診る?どう治す?薬剤によって誘発される自己免疫性水疱症

Author (1)： YAMAGAMI JUN (慶応大 医 皮膚科学)
Material： Monthly Book Derma.  (MB Derma)
Issue： 292  Page： 38-44  Publication year： Feb. 15, 2020 
JST Material Number： L3871A  ISSN： 1343-0831  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *autoimmune disease ,...
Semi thesaurus term： *Auto-immune bullosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0560451&from=J-GLOBAL&jstjournalNo=L3871A") }}

JST classification (2)： Skin diseases  (GF03000Q) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Substance index (1)： Vancomycin

Reference (14)：

• Skandalis K, Spirova M, Gaitanis G, et al : Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. J Eur Acad Dematol Veneoreol, 26 : 249-253,2012.
• Bene J, Moulis G, Bennani I, et al : Bullous pemphigoid and dipeptidyl peptidase IV inhibitors : a case-nocase study in the French Pharmacovigilance Database. Br J Dermatol, 175 : 296-301, 2016.
• Arai M, Shirakawa J, Konishi H, et al : Bullous pemphigoid and dipeptidyl peptidase 4 inhibitors : a disproportionality analysis based on the Japanese adverse drug event report database. Diabetes Care, 41 : e130-132, 2018.
• Varpuluoma O, Forsti AK, Jokelainen J, et al : Vildagliptin significantly increases the risk of bullous pemphigoid : a Finnish nationwide registry study. J Invest Dermatol, 138 : 1659-1661, 2018.
• Kridin K, Bergman R : Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes : estimating the risk of the new agents and characterizing the patients. JAMA Dermatol, 154 : 1152-1158,2018.

Terms in the title (4)： 水疱 ,  薬剤 ,  誘発 ,  自己免疫性水疱症